申请人:KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
公开号:US11192878B2
公开(公告)日:2021-12-07
The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.
本公开涉及一种新型哌啶-2,6-二酮衍生物及其用途,更具体地说,涉及一种具有沙利度胺类似物结构的哌啶-2,6-二酮衍生物化合物。根据本公开的化学式 1 的化合物能特异性地与 CRBN 蛋白结合,并参与其功能。因此,本公开的化合物可用于预防或治疗由 CRBN 蛋白作用引起的麻风病、慢性移植物抗宿主疾病、炎症性疾病或癌症。